Last reviewed · How we verify

NCT06908408: BE-Platelet

Correlation Between Base Excess in Patients Upon Admission to the ICU and Platelet Count Trend in the Following Days

Completed Last updated 3 April 2025
What this trial tests

trial testing Corrrelation between metabolic acidosis severity in patients on admission to the ICU and platelet count trend in 2 days following admission was investigated in Platelet Count Decline in Critically Ill in 484 participants. Completed in 14 February 2024.

Timeline
11 January 2024
Primary endpoint
11 February 2024
14 February 2024

Quick facts

Lead sponsorUniversity Medical Centre Ljubljana
StatusCompleted
Study typeOBSERVATIONAL
Enrollment484
Start date11 January 2024
Primary completion11 February 2024
Estimated completion14 February 2024
Sites1 location across Slovenia

Drugs / interventions tested

Conditions studied

Sponsor

University Medical Centre Ljubljana

Who can join

14 and older, any sex, with Platelet Count Decline in Critically Ill or Metabolic Acidosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Several studies have revealed that a relative platelet count decline in patients after their admission to the intensive care unit (ICU) is a very reliable marker of the severity of their sickness. ICU patients with a greater platelet count decline after their admission to the ICU have generally worse outcome. Investigators assume that a quick appearance of a deep metabolic acidosis, which commonly occurs in critically ill, has an important role in pathogenesis of relative platelet count decline. To evaluate this, correlation of metabolic acidosis severity in participants upon admission to the ICU with platelet count decline in 2 days, following admission, was investigated with a retrospective observational study, analysing all participants, admitted to the ICU in one year period (in 2020). As a measurement of metabolic acidosis severity, investigators took base excess (BE) value (expressed in mmol/L) from arterial blood gas analysis with lowest pH in participants in around admission time (in a period from 24 hours before to 24 hours after their admission to the ICU). To calculate relative platelet count decline in 2 days after admission to the ICU, investigators took platelet count on admission to the ICU (P0) and lowest platelet count on day 2 after the patient's admission (P2). Following formula was used to calculate relative platelet count decline in 2 days after ICU admission (delta P): delta P = (P2-P0)/P0 x 100 (expressed in %). More negative values of delta P represent larger relative platelet count decline. The main interest of the study was if BE value correlates with delta P. Investigators assumed that participants with a more severe metabolic acidosis upon admission to the ICU (represented with more negative BE value) would tend to have a larger relative platelet count decline in 2 days, following admission to the ICU (represented with more negative value of delta P). Pearson correlation was used to evaluate correlation between BE and delta P.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Medical Centre Ljubljana trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06908408.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing